StockWatch
·
Pharmaceuticals
Board Meeting28 Sept 2026, 07:20 pm

Cipla Ltd Board Meeting on Oct 27, 2026 for Q2 FY27 Results

AI Summary

Cipla Ltd has announced that its Board of Directors will convene on October 27, 2026. The primary agenda item for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company will enforce a trading window closure from October 1, 2026, to October 29, 2026, inclusive, in accordance with its insider trading code, to prevent any potential misuse of information related to the financial results.

Key Highlights

  • Board meeting scheduled for October 27, 2026.
  • To approve unaudited standalone and consolidated financial results.
  • Results pertain to the quarter and half-year ended September 30, 2026.
  • Trading window closed from October 1 to October 29, 2026.